tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Flaviviridae Infections D018178 1 associated lipids
Megacolon, Toxic D008532 1 associated lipids
Lichen Sclerosus et Atrophicus D018459 2 associated lipids
Leukemia, Biphenotypic, Acute D015456 2 associated lipids
Lichenoid Eruptions D017512 1 associated lipids
Herpes Labialis D006560 1 associated lipids
Pemphigus D010392 3 associated lipids
Mutism D009155 1 associated lipids
Neurodermatitis D009450 1 associated lipids
Leukoplakia, Oral D007972 1 associated lipids
Hypertensive Encephalopathy D020343 1 associated lipids
Skin Diseases, Viral D017193 2 associated lipids
Cytomegalovirus Retinitis D017726 2 associated lipids
Rectal Fistula D012003 2 associated lipids
Vestibular Diseases D015837 2 associated lipids
Intestinal Atresia D007409 3 associated lipids
Priapism D011317 1 associated lipids
Kaposi Varicelliform Eruption D007617 1 associated lipids
Echinostomiasis D004451 1 associated lipids
Respiratory Tract Neoplasms D012142 2 associated lipids
Trichomonas Infections D014245 3 associated lipids
Deltaretrovirus Infections D006800 1 associated lipids
West Nile Fever D014901 1 associated lipids
Foot Ulcer D016523 4 associated lipids
Fibroadenoma D018226 2 associated lipids
Tinea Capitis D014006 1 associated lipids
Pancreatic Fistula D010185 2 associated lipids
Facial Nerve Injuries D020220 1 associated lipids
Lymphocele D008210 1 associated lipids
End Stage Liver Disease D058625 1 associated lipids
Thrombotic Microangiopathies D057049 1 associated lipids
Angiofibroma D018322 2 associated lipids
Posterior Leukoencephalopathy Syndrome D054038 1 associated lipids
Peroneal Neuropathies D020427 1 associated lipids
Hearing Loss, Bilateral D006312 1 associated lipids
Cheilitis D002613 2 associated lipids
Still's Disease, Adult-Onset D016706 2 associated lipids
Hidradenitis Suppurativa D017497 2 associated lipids
Lymphocytic Choriomeningitis D008216 1 associated lipids
Necrobiosis Lipoidica D009335 2 associated lipids
Vulvar Lichen Sclerosus D007724 1 associated lipids
Neuromyelitis Optica D009471 2 associated lipids
Optic Neuritis D009902 1 associated lipids
Dysplastic Nevus Syndrome D004416 1 associated lipids
Epidermolysis Bullosa D004820 3 associated lipids
Dendritic Cell Sarcoma, Interdigitating D054739 1 associated lipids
Epidermolysis Bullosa Dystrophica D016108 1 associated lipids
Churg-Strauss Syndrome D015267 2 associated lipids
Myelinolysis, Central Pontine D017590 1 associated lipids
Balanitis D001446 4 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Cho JH et al. Development of novel fast-dissolving tacrolimus solid dispersion-loaded prolonged release tablet. 2014 Eur J Pharm Sci pmid:24388864
Smoter P et al. Risk factors of acute renal failure after orthotopic liver transplantation: single-center experience. 2014 Transplant. Proc. pmid:25380918
Frassetto LA et al. Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients. 2014 Transplantation pmid:24389906
Lerut JP et al. Is minimal, [almost] steroid-free immunosuppression a safe approach in adult liver transplantation? Long-term outcome of a prospective, double blind, placebo-controlled, randomized, investigator-driven study. 2014 Ann. Surg. pmid:25379858
Hitzler JK et al. Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome. 2014 Pediatr Blood Cancer pmid:24391118
Wu Y et al. Increased macrophage activation inhibited by tacrolimus in the kidney of diabetic rats. 2014 Nephron Exp. Nephrol. pmid:25376933
Levitsky J and Feng S Sirolimus and mTOR inhibitors in liver transplantation: the wheel has come full circle. 2014 Am. J. Transplant. pmid:24620373
Catalano G et al. Everolimus-based immunosuppression in a case of ABO-incompatible liver transplantation with calcineurin inhibitor-related posterior occipital syndrome. 2014 Transpl. Int. pmid:24606320
Zhang Y et al. Genome-wide identification and analysis of FK506-binding protein gene family in peach (Prunus persica). 2014 Gene pmid:24342662
Muhetaer G et al. Clinical significance of peripheral blood lymphocyte sensitivity to glucocorticoids for the differentiation of high-risk patients with decreased allograft function after glucocorticoid withdrawal in renal transplantation. 2014 Clin Ther pmid:25037282
Shin BH et al. Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents. 2014 Transplantation pmid:24342979
Tavira B et al. [Pharmacogenetics of tacrolimus: from bench to bedside?]. 2014 Nefrologia pmid:24463861
Qin XL et al. Effect of Tacrolimus on the pharmacokinetics of bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) and the potential roles of CYP3A and P-gp. 2014 Phytomedicine pmid:24462213
Asrani SK et al. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. 2014 Am. J. Transplant. pmid:24456026
Nevers W et al. Safety of tacrolimus in pregnancy. 2014 Can Fam Physician pmid:25316742
Oellerich M et al. Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation. 2014 Ther Drug Monit pmid:24452066
Wang J et al. Molecular mechanisms of FK506-induced hypertension in solid organ transplantation patients. 2014 Chin. Med. J. pmid:25316243
Ducroux E et al. Hidradenitis suppurativa after renal transplantation: complete remission after switching from oral cyclosporine to oral tacrolimus. 2014 J. Am. Acad. Dermatol. pmid:25437996
Khorrami A et al. Tacrolimus ameliorates functional disturbances and oxidative stress in isoproterenol-induced myocardial infarction. 2014 Daru pmid:25312839
Shimizu M et al. Successful multitarget therapy using mizoribine and tacrolimus for refractory Takayasu arteritis. 2014 Rheumatology (Oxford) pmid:24609060
Golubović B et al. Total plasma protein effect on tacrolimus elimination in kidney transplant patients--population pharmacokinetic approach. 2014 Eur J Pharm Sci pmid:24184751
Hu YM et al. Casein kinase II inhibition reverses pain hypersensitivity and potentiated spinal N-methyl-D-aspartate receptor activity caused by calcineurin inhibitor. 2014 J. Pharmacol. Exp. Ther. pmid:24610957
Bäckman L and Persson CA An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients. 2014 Ann. Transplant. pmid:24637379
Mai HL et al. IL-7 receptor blockade following T cell depletion promotes long-term allograft survival. 2014 J. Clin. Invest. pmid:24569454
Tokuoka H et al. Nurr1 expression is regulated by voltage-dependent calcium channels and calcineurin in cultured hippocampal neurons. 2014 Neurosci. Lett. pmid:24291696
Boran M et al. Determining renal resistive and pulsatility indexes long-term after kidney transplantation in kidney transplant recipients on cyclosporine a-, tacrolimus-, or sirolimus-based regimens. 2014 Transplant. Proc. pmid:24935296
Fuchs U et al. Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus. 2014 Transpl. Immunol. pmid:24932812
Motomura H et al. Inhibitory effect of tacrolimus on progression of joint damage in patients with rheumatoid arthritis. 2014 Int J Rheum Dis pmid:24251619
Han N et al. Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation. 2014 Basic Clin. Pharmacol. Toxicol. pmid:24238261
Yasukochi Y et al. Reduction of serum TARC levels in atopic dermatitis by topical anti-inflammatory treatments. 2014 Asian Pac. J. Allergy Immunol. pmid:25268342
Zhang L et al. Ambrisentan improves the outcome of rats with liver transplantation partially through reducing nephrotoxicity. 2014 Eur Rev Med Pharmacol Sci pmid:25268107
Donnadieu B et al. Central retinal vein occlusion-associated tacrolimus after liver transplantation. 2014 Transplantation pmid:25955343
Rangel EB Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug-drug interactions. 2014 Expert Opin Drug Metab Toxicol pmid:25255841
Sharp WW et al. Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission. 2014 FASEB J. pmid:24076965
Al-Harbi NO et al. Protection against tacrolimus-induced cardiotoxicity in rats by olmesartan and aliskiren. 2014 Toxicol. Mech. Methods pmid:25199528
Wilusz M et al. Effect of immunosuppressive therapy on the serum fatty acids of phospholipids fraction in patients after heart transplantation. 2014 Transplant. Proc. pmid:25380928
Notaro E et al. Dose conversion factor between cyclosporine and tacrolimus in pediatric heart transplant recipients. 2014 J. Heart Lung Transplant. pmid:24854566
Lan CC et al. Tacrolimus abrogates TGF-β1-induced type I collagen production in normal human fibroblasts through suppressing p38MAPK signalling pathway: implications on treatment of chronic atopic dermatitis lesions. 2014 J Eur Acad Dermatol Venereol pmid:23301526
Burroughs LM et al. Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial. 2014 Biol. Blood Marrow Transplant. pmid:25196857
Guy-Viterbo V et al. Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach. 2014 Pharmacogenomics pmid:25141896
Cavalli RC et al. Analysis of the histology of the scar bladder and biochemical parameters of rats with a solitary kidney undergoing immunosuppression with tacrolimus. 2014 Acta Cir Bras pmid:25140592
Mabe S et al. Detecting protein-protein interactions based on kinase-mediated growth induction of mammalian cells. 2014 Sci Rep pmid:25135216
Sol Fustiñana M et al. Protein degradation by ubiquitin-proteasome system in formation and labilization of contextual conditioning memory. 2014 Learn. Mem. pmid:25135196
Elens L et al. Impact of POR*28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patients. 2014 Ther Drug Monit pmid:24061445
Imataki O et al. Reversible cerebral vasoconstriction syndrome resulted in cerebral infarction after allogeneic stem cell transplantation: a case report. 2014 Ann. Hematol. pmid:24061786
Hagihara Y et al. Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease. 2014 J Crohns Colitis pmid:24011513
Kilinc S et al. The effects of preoperative immunosuppressive therapy on ischemia and reperfusion (I/R) injury in healthy rats. 2014 Int Urol Nephrol pmid:24014133
Gürkan A et al. Alpha 2 integrin gene (ITGA2) polymorphism in renal transplant recipients with and without drug induced gingival overgrowth. 2014 Arch. Oral Biol. pmid:24581850
Spasovski G and Masin-Spasovska J How to improve the survival of the kidney transplant - is it only the pharmaceutical management? 2014 Expert Opin Pharmacother pmid:24617949
Shen T et al. A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure. 2014 HBPD INT pmid:25100124
Wang B et al. Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats. 2014 J Ethnopharmacol pmid:25091466
Bao J and Liang H Tacrolimus-induced permanent asymptomatic pontine myelinolysis after liver transplantation. 2014 Intern. Med. pmid:25088893
Verghese PS et al. Calcineurin inhibitors in HLA-identical living related donor kidney transplantation. 2014 Nephrol. Dial. Transplant. pmid:24414376
Da-Long S et al. Tacrolimus on Kimura's disease: a case report. 2014 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:22939325
Kyriakou A et al. Therapeutic efficacy of topical calcineurin inhibitors in plasma cell balanitis: case series and review of the literature. 2014 Dermatology (Basel) pmid:24434685
Thapa RK and Yoo BK Evaluation of the effect of tacrolimus-loaded liquid crystalline nanoparticles on psoriasis-like skin inflammation. 2014 J Dermatolog Treat pmid:23210668
Viecelli A et al. Diagnostic and management dilemma of a pancreas-kidney transplant recipient with aplastic anaemia. 2014 BMJ Case Rep pmid:25257886
Yamazoe K et al. Efficacy and safety of systemic tacrolimus in high-risk penetrating keratoplasty after graft failure with systemic cyclosporine. 2014 Cornea pmid:25255133
Jaksch P et al. Alemtuzumab in lung transplantation: an open-label, randomized, prospective single center study. 2014 Am. J. Transplant. pmid:25039364
Segarra-Medrano A et al. Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus. 2014 Nefrologia pmid:25036063
Bax K et al. Rapid resolution of tacrolimus intoxication-induced AKI with a corticosteroid and phenytoin. 2014 Ann Pharmacother pmid:25104567
John K et al. Role of dendritic cells in the context of acute cellular rejection: comparison between tacrolimus- or cyclosporine A-treated heart transplanted recipients. 2014 Cytometry B Clin Cytom pmid:24668729
Dessilly G et al. ABCB1 1199G>A genetic polymorphism (Rs2229109) influences the intracellular accumulation of tacrolimus in HEK293 and K562 recombinant cell lines. 2014 PLoS ONE pmid:24621983
Falconer SJ et al. Conversion from twice-daily to once-daily tacrolimus in simultaneous pancreas-kidney transplant patients. 2014 Transplant. Proc. pmid:24935313
Terada Y et al. Intestinal P-glycoprotein expression is multimodally regulated by intestinal ischemia-reperfusion. 2014 J Pharm Pharm Sci pmid:24934555
Goring SM et al. A network meta-analysis of the efficacy of belatacept, cyclosporine and tacrolimus for immunosuppression therapy in adult renal transplant recipients. 2014 Curr Med Res Opin pmid:24628478
Mai S et al. In vitro and in vivo release characteristics of Tacrolimus (FK506) from an episcleral drug-delivery implant. 2014 J Ocul Pharmacol Ther pmid:24933028
Urbanowicz T et al. Comparison of conventional tacrolimus versus prolong release formula as initial therapy in heart transplantation. 2014 Ann. Transplant. pmid:24949728
Nomura H et al. A patient with lupus miliaris disseminatus faciei treated successfully with a combination of oral metronidazole and topical tacrolimus. 2014 J. Dermatol. pmid:24931738
Fuchs U et al. Incidence of malignant neoplasia after heart transplantation--a comparison between cyclosporine a and tacrolimus. 2014 Ann. Transplant. pmid:24953848
Rahman Z et al. Near-infrared and fourier transform infrared chemometric methods for the quantification of crystalline tacrolimus from sustained-release amorphous solid dispersion. 2014 J Pharm Sci pmid:24931728
Elamin S et al. Co-administration of ketoconazole and tacrolimus to kidney transplant recipients: cost minimization and potential metabolic benefits. 2014 Saudi J Kidney Dis Transpl pmid:24969193
Gibbs BF et al. Highly specific targeting of human leukocytes using gold nanoparticle-based biologically active conjugates. 2014 J Biomed Nanotechnol pmid:24804546
Richards KR et al. Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients. 2014 Transplantation pmid:24784360
Cutler C et al. Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. 2014 Blood pmid:24982504
Liu Z et al. Tacrolimus-based versus cyclosporine-based immunosuppression in hepatitis C virus-infected patients after liver transplantation: a meta-analysis and systematic review. 2014 PLoS ONE pmid:25198195
Katayama M et al. Preliminary study of interaction of clarithromycin with tacrolimus in cats. 2014 J. Vet. Med. Sci. pmid:25099737
Shihab F et al. Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes. 2014 Transpl. Immunol. pmid:24861504
Almeida-Paulo GN et al. Limited sampling strategies for tacrolimus exposure (AUC0-24) prediction after Prograf(®) and Advagraf(®) administration in children and adolescents with liver or kidney transplants. 2014 Transpl. Int. pmid:24861353
Kahvecioglu S et al. Effects of calcineurin inhibitors on paraoxonase and arylesterase activity after a kidney transplant. 2014 Exp Clin Transplant pmid:24447269
Marin-Casino M et al. Significant tacrolimus and dronedarone interaction in a kidney transplant recipient. 2014 Transplantation pmid:25243519
Chamienia A et al. Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results. 2014 Transplant. Proc. pmid:25380901
Doren EL and Aya-ay ML Pyoderma gangrenosum following breast reduction: treatment with topical tacrolimus and steroids. 2014 Aesthet Surg J pmid:24448967
Lee CM et al. Monotherapy with tacrolimus for heart and liver transplant: a case report. 2014 Transplant. Proc. pmid:24767396
Lin YH and Pratt MR A dual small-molecule rheostat for precise control of protein concentration in Mammalian cells. 2014 Chembiochem pmid:24615791
Abe T et al. Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation. 2014 Transplant. Proc. pmid:24767367
Mita A et al. Optimal initial dose of orally administered once-daily extended-release tacrolimus following intravenous tacrolimus therapy after liver transplantation. 2014 Transplant. Proc. pmid:24767351
Jin L et al. Dipeptidyl peptidase IV inhibitor MK-0626 attenuates pancreatic islet injury in tacrolimus-induced diabetic rats. 2014 PLoS ONE pmid:24959755
Hashi S et al. Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients. 2014 Transplant. Proc. pmid:24767342
Wan XC and Dimov V Pharmacokinetic evaluation of topical calcineurin inhibitors for treatment of allergic conjunctivitis. 2014 Expert Opin Drug Metab Toxicol pmid:24490943
Zhang X et al. Profiling of drug binding proteins by monolithic affinity chromatography in combination with liquid chromatography-tandem mass spectrometry. 2014 J Chromatogr A pmid:25064533
Chen C et al. Rapid construction of a Bacterial Artificial Chromosomal (BAC) expression vector using designer DNA fragments. 2014 Plasmid pmid:25454071
Olson KA et al. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease. 2014 Pharmacotherapy pmid:24700567
Momohara S et al. Recent trends in orthopedic surgery aiming to improve quality of life for those with rheumatoid arthritis: data from a large observational cohort. 2014 J. Rheumatol. pmid:24692532
Lin Q et al. Pharmacological mobilization of endogenous stem cells significantly promotes skin regeneration after full-thickness excision: the synergistic activity of AMD3100 and tacrolimus. 2014 J. Invest. Dermatol. pmid:24682043
Díaz-García C et al. Pregnancy after allogeneic uterus transplantation in the rat: perinatal outcome and growth trajectory. 2014 Fertil. Steril. pmid:25439799
Tsunashima D et al. Assessment of tacrolimus absorption from the human intestinal tract: open-label, randomized, 4-way crossover study. 2014 Clin Ther pmid:24680768
Ibrahim O et al. The role of infliximab in the treatment of superficial granulomatous pyoderma of the head and neck. 2014 J. Am. Acad. Dermatol. pmid:25438004
Kraaij MD et al. Human monocytes produce interferon-gamma upon stimulation with LPS. 2014 Cytokine pmid:24680476
Sawamoto K et al. Mechanisms of lower maintenance dose of tacrolimus in obese patients. 2014 Drug Metab. Pharmacokinet. pmid:24670405